Entry Point Capital, LLC Ardelyx, Inc. Transaction History
Entry Point Capital, LLC
- $221 Million
- Q4 2024
A detailed history of Entry Point Capital, LLC transactions in Ardelyx, Inc. stock. As of the latest transaction made, Entry Point Capital, LLC holds 33,323 shares of ARDX stock, worth $180,943. This represents 0.08% of its overall portfolio holdings.
Number of Shares
33,323
Previous 16,399
103.2%
Holding current value
$180,943
Previous $112,000
53.57%
% of portfolio
0.08%
Previous 0.07%
Shares
3 transactions
Others Institutions Holding ARDX
# of Institutions
232Shares Held
150MCall Options Held
1.54MPut Options Held
3.08M-
Janus Henderson Group PLC London, X024.4MShares$132 Million0.07% of portfolio
-
Black Rock Inc. New York, NY17.6MShares$95.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA14.4MShares$78 Million0.0% of portfolio
-
State Street Corp Boston, MA11.6MShares$62.9 Million0.0% of portfolio
-
Macquarie Group LTD Australia, C310.3MShares$56.2 Million0.06% of portfolio
About ARDELYX, INC.
- Ticker ARDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 154,636,000
- Market Cap $840M
- Description
- Ardelyx, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat gastrointestinal and cardiorenal therapeutic areas in the United States and internationally. The company's lead product candidate is tenapanor, which has completed Phase III clinical trial for the treatment of patients with irritable bowel synd...